Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Schmitz

Showing results (231-240 of 385) with videos related to

Pageof 39
Sort By:
BMC Psychiatry|April 17, 2015
A five-year randomized parallel and blinded clinical trial of an extended specialized early intervention vs. regular care in the early phase of psychotic disorders: study protocolDanyael Lutgens, Srividya Iyer, Ridha Joober, et al.
Psychological Medicine|September 28, 2020
Context and contact: a comparison of patient and family engagement with early intervention services for psychosis in India and CanadaSrividya N Iyer, Ashok Malla, Aarati Taksal, et al.
HRB Open Research|March 30, 2026
"We are more than just a number": Mental health needs in the context of diabetes healthcare in IrelandJaroslav Gottfried, Amanda Fitzgerald, Gráinne Flynn, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 27, 2008
COMT Val108/158Met polymorphism and the modulation of task-oriented behavior in children with ADHDSarojini Sengupta, Natalie Grizenko, Norbert Schmitz, et al.
Haematologica|February 13, 2008
A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapyNigel Russell, Rolf Mesters, Joerg Schubert, et al.
Annals of Hematology|April 15, 2025
Lenalidomide in combination with rituximab, dexamethasone, high-dose ARA-C and cisplatinum as salvage therapy in refractory or relapsed aggressive B-cell non-hodgkin-lymphoma - an open-label, multicentre phase I/II study (DSHNHL-R6)Stephan Fuhrmann, Maike Nickelsen, Justin Hasenkamp, et al.
Bone Marrow Transplantation|November 11, 2018
Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced diseaseGerald Wulf, Justin Hasenkamp, Wolfram Jung, et al.
British Journal of Haematology|March 8, 2008
Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphomaJorg Basecke, Martina Podleschny, Annegret Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2008
Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter studyPeter Reimer, Thomas Rüdiger, Eva Geissinger, et al.
Cancer|April 22, 2011
Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphomaSascha Dietrich, Blanca Tielesch, Michael Rieger, et al.
Pageof 39

Showing results (231-240 of 385) with videos related to

Sort By:
Pageof 39
BMC Psychiatry|April 17, 2015
A five-year randomized parallel and blinded clinical trial of an extended specialized early intervention vs. regular care in the early phase of psychotic disorders: study protocolDanyael Lutgens, Srividya Iyer, Ridha Joober, et al.
Psychological Medicine|September 28, 2020
Context and contact: a comparison of patient and family engagement with early intervention services for psychosis in India and CanadaSrividya N Iyer, Ashok Malla, Aarati Taksal, et al.
HRB Open Research|March 30, 2026
"We are more than just a number": Mental health needs in the context of diabetes healthcare in IrelandJaroslav Gottfried, Amanda Fitzgerald, Gráinne Flynn, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 27, 2008
COMT Val108/158Met polymorphism and the modulation of task-oriented behavior in children with ADHDSarojini Sengupta, Natalie Grizenko, Norbert Schmitz, et al.
Haematologica|February 13, 2008
A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapyNigel Russell, Rolf Mesters, Joerg Schubert, et al.
Annals of Hematology|April 15, 2025
Lenalidomide in combination with rituximab, dexamethasone, high-dose ARA-C and cisplatinum as salvage therapy in refractory or relapsed aggressive B-cell non-hodgkin-lymphoma - an open-label, multicentre phase I/II study (DSHNHL-R6)Stephan Fuhrmann, Maike Nickelsen, Justin Hasenkamp, et al.
Bone Marrow Transplantation|November 11, 2018
Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced diseaseGerald Wulf, Justin Hasenkamp, Wolfram Jung, et al.
British Journal of Haematology|March 8, 2008
Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphomaJorg Basecke, Martina Podleschny, Annegret Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2008
Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter studyPeter Reimer, Thomas Rüdiger, Eva Geissinger, et al.
Cancer|April 22, 2011
Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphomaSascha Dietrich, Blanca Tielesch, Michael Rieger, et al.
Pageof 39